Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pain 1Mastodynia 1Fibrosis 1Fibrocystic Breast Disease 1Cysts 1

Interventions

Trastuzumab 242Paclitaxel 223Fulvestrant 196Capecitabine 182Docetaxel 164Letrozole 142pembrolizumab 115Carboplatin 100exemestane 98Gemcitabine 98Cyclophosphamide 92palbociclib 86Anastrozole 83pertuzumab 78Lapatinib 73Bevacizumab 71ribociclib 68130-nm albumin-bound paclitaxel 66abemaciclib 59eribulin 58Doxorubicin 55Vinorelbine 51Injections 47Ado-Trastuzumab Emtansine 47Tamoxifen 45Everolimus 44Albumin-Bound Paclitaxel 44atezolizumab 35trastuzumab deruxtecan 34Nivolumab 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Iodides × Breast × Clear all
NCT00237523 2007-06-18

Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast Pain

Symbollon Pharmaceuticals

Phase 3 Unknown
175 enrolled
Breast

Cysts, Fibrocystic Breast Disease, Fibrosis, Pain, Mastodynia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡